Stock A065650 HYPER CORPORATION INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Hyper Corporation Inc.

Equities

A065650

KR7065650004

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-04 pm EDT 		5-day change 1st Jan Change
1,404 KRW -1.54% Intraday chart for Hyper Corporation Inc. -2.57% +42.83%
May. 30 Hyper Corporation Inc. completed the acquisition of unknown minority stake in Fingerlabs Co., Ltd. from FSN Co., Ltd. and AdQUA Interactive Inc. CI
May. 30 AdQUA Interactive Inc. completed the acquisition of 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd.. CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Hyper Corporation Inc. completed the acquisition of unknown minority stake in Fingerlabs Co., Ltd. from FSN Co., Ltd. and AdQUA Interactive Inc.
CI
AdQUA Interactive Inc. completed the acquisition of 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd..
CI
Medifron DBT Co., Ltd. completed the acquisition of 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd..
CI
Medifron DBT Co., Ltd. announced that it has received KRW 20.999999826 billion in funding from FSN Co., Ltd.
CI
Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd..
CI
AdQUA Interactive Inc. agreed to acquire 48% stake in Emotion Global, Inc. from Medifron DBT Co., Ltd. for KRW 5.9 billion.
CI
Medifron DBT Co., Ltd. agreed to acquire 19.49% stake in Makeus Co.,Ltd. from FSN Co., Ltd. for KRW 7.9 billion.
CI
FSN Co., Ltd., AI Tech Fund, Asset Plus Fund and Open Innovation Fund managed by Benex Investment completed the acquisition of a 22.4% stake in Medifron DBT Co., Ltd. from Hansung Cleantech Co., Ltd. and T Scientific Co.,Ltd.
CI
EN Creative Co., Ltd. agreed to acquire HMR business of Medifron DBT Co., Ltd. for KRW 5.7 billion
CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 41.999999652 billion in funding
CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 20.999999826 billion in funding from FSN Co., Ltd.
CI
Medifron DBT Co., Ltd. announced that it has received KRW 4.0000092 billion in funding from T Scientific Co.,Ltd
CI
Medifron DBT Co., Ltd.(KOSDAQ:A065650) dropped from S&P Global BMI Index
CI
Medifron DBT Co., Ltd. announced that it has received KRW 3 billion in funding
CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 3 billion in funding
CI
Medifron DBT Co., Ltd. announced that it has received KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.
CI
Medifron DBT to Raise $3.9 Million via Stock Offering
MT
Medifron DBT to Raise $10 Million via Stock Offering
MT
Medifron DBT Co., Ltd. announced that it expects to receive KRW 5 billion in funding from Shinhan Financial Investment Co., Ltd., Mirae Asset Securities Co. Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd.
CI
Medifron DBT Co., Ltd. announced that it expects to receive KRW 12.9999915 billion in funding from Best Investment & Securities Co., Ltd., Hanyang Securities Co. Ltd., Korea Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., KB Securities Co., Ltd. and other investors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A065650 Stock
  4. News Hyper Corporation Inc.